Literature DB >> 36255646

Surgical Management of Gastro-oesophageal Reflux Disease After One Anastomosis Gastric Bypass - a Systematic Review.

Rachel Xue Ning Lee1, Nayer Rizkallah1, Sonja Chiappetta2, Christine Stier3, Sjaak Pouwels4, Nasser Sakran5,6, Rishi Singhal7, Kamal Mahawar8,9, Brijesh Madhok10.   

Abstract

Gastro-oesophageal reflux disease (GORD) after one anastomosis gastric bypass (OAGB) remains a concern. We reviewed the current literature on revisional surgery after OAGB for GORD. MEDLINE, EMBASE, and PubMed databases were searched. We identified 21 studies, appraising 13,658 OAGB patients. A total of 230 (1.6%) patients underwent revisional surgery for GORD. Revision to Roux-en-Y configuration was performed in 211 (91.7%) patients. Six (2.6%) patients had a Braun entero-enterostomy added to the OAGB. Thirteen (5.6%) patients underwent excluded stomach fundoplication (ESF). Reflux symptoms resolved in 112 (48.6%) patients, persisted in 13 (5.6%) patients, and were not reported in 105 (45.6%) patients. Revisional surgery after OAGB for GORD appears to be rare, and when required, conversion to Roux-en-Y configuration is the commonest choice.
© 2022. Crown.

Entities:  

Keywords:  Acid reflux; Bile reflux; Gastro-oesophageal reflux; Loop gastric bypass; Mini gastric bypass; Omega loop gastric bypass; One anastomosis gastric bypass

Year:  2022        PMID: 36255646     DOI: 10.1007/s11695-022-06301-8

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   3.479


  33 in total

1.  The mini-gastric bypass: experience with the first 1,274 cases.

Authors:  R Rutledge
Journal:  Obes Surg       Date:  2001-06       Impact factor: 4.129

2.  Short- and Mid-term Outcomes of 527 One Anastomosis Gastric Bypass/Mini-Gastric Bypass (OAGB/MGB) Operations: Retrospective Study.

Authors:  A Hussain; S El-Hasani
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

3.  Still "controversies" about the mini gastric bypass?

Authors:  Mario Musella; Marco Milone
Journal:  Obes Surg       Date:  2014-04       Impact factor: 4.129

4.  Gastric bypass in obesity.

Authors:  E E Mason; C Ito
Journal:  Surg Clin North Am       Date:  1967-12       Impact factor: 2.741

5.  GORD and Barrett's oesophagus after bariatric procedures: multicentre prospective study.

Authors:  Alfredo Genco; Lidia Castagneto-Gissey; Loredana Gualtieri; Marcello Lucchese; Luca Leuratti; Emanuele Soricelli; Giovanni Casella
Journal:  Br J Surg       Date:  2021-12-01       Impact factor: 6.939

6.  Mini Gastric Bypass-One Anastomosis Gastric Bypass (MGB-OAGB)-IFSO Position Statement.

Authors:  Maurizio De Luca; Tiffany Tie; Geraldine Ooi; Kelvin Higa; Jacques Himpens; Miguel-A Carbajo; Kamal Mahawar; Scott Shikora; Wendy A Brown
Journal:  Obes Surg       Date:  2018-05       Impact factor: 4.129

Review 7.  One anastomosis gastric bypass: key technical features, and prevention and management of procedure-specific complications.

Authors:  Kamal K Mahawar; Chetan Parmar; Yitka Graham
Journal:  Minerva Chir       Date:  2018-07-18       Impact factor: 1.000

8.  Efficacy of Bariatric Surgery in Type 2 Diabetes Mellitus Remission: the Role of Mini Gastric Bypass/One Anastomosis Gastric Bypass and Sleeve Gastrectomy at 1 Year of Follow-up. A European survey.

Authors:  Mario Musella; Jan Apers; Karl Rheinwalt; Rui Ribeiro; Emilio Manno; Francesco Greco; Michal Čierny; Marco Milone; Carla Di Stefano; Sahin Guler; Isa Mareike Van Lessen; Anabela Guerra; Mauro Natale Maglio; Riccardo Bonfanti; Radoslava Novotna; Guido Coretti; Luigi Piazza
Journal:  Obes Surg       Date:  2016-05       Impact factor: 4.129

9.  [Evidence of the Mini-/One-anastomosis-gastric-Bypass for being a standard procedure in obesity and metabolic surgery].

Authors:  S Chiappetta; R Weiner
Journal:  Chirurg       Date:  2018-08       Impact factor: 0.955

10.  IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures.

Authors:  Luigi Angrisani; A Santonicola; P Iovino; A Vitiello; K Higa; J Himpens; H Buchwald; N Scopinaro
Journal:  Obes Surg       Date:  2018-12       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.